// App-Quantinova.ai

3788 : Monitoring of multimodality immune checkpoint inhibitor treatment efficacy in metastatic melanoma patients through molecular analysis of circulating tumor cells

Researchers

Presenter

  • Selena Lin

Principal Investigators

  • Stella Lam

  • Shuichi Ohe

  • Kevin Tran

  • Irene Ramos

  • Ali Asgar Bhagat

  • Chwee Teck Lim

  • Steven J. O'Day

  • Leland Foshag

  • Dave Hoon

Medical Centers

  • John Wayne Cancer Institute, Santa Monica, CA

  • Clearbridge Biomedics Pte Ltd, Singapore, Singapore

  • National University of Singapore, Singapore

Locations

  • United States

  • Singapore

Companies

  • Clearbridge BioMedic

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Circulating tumor cells

  • Melanoma-associated antigen (MAGE)-A3

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • II/III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved